English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduAustralian researchers say access to a free medicated nasal spray which temporarily reverses the effects of opioid toxicity while waiting for an ambulance to arrive, will save lives and reduce opioid-related hospital admissions.
Tag: Naloxone
A 37% drop in overdose deaths from drugs mixed with opioids – fentanyl included
Expanded treatment options, increased naloxone distribution and targeted education campaigns likely led to a 37% reduction in overdose deaths from opioids combined with stimulant drugs other than cocaine, according to the results of a large federally funded study.
Can naloxone improve survival rates of patients with cardiac arrest?
A new study from UC Davis Health assessed the link between naloxone administration by paramedics and the clinical outcomes for patients with out of hospital cardiac arrest.
Experimental drug supercharges medicine that reverses opioid overdose
Researchers at Washington University School of Medicine in St. Louis, with collaborators at the University of Florida and Stanford University, identified a compound that, in mice, makes naloxone much more effective at counteracting a drug overdose.
High out-of-pocket costs may be barrier to filling naloxone prescriptions, study shows
A study finds naloxone prescriptions, given to prevent opioid overdoses, are less likely to be filled when cost-sharing is higher, including at the start of a new health insurance year.
A step to prevent opioid overdose deaths with light-activated naloxone treatment
In a proof-of-concept in ACS’ Nano Letters, a team has designed injectable nanoparticles that released naloxone ― which rapidly reverses opioid overdose effects ― when triggered by blue light. In experiments with mice, this system was activated a month after injection.
U.S. Drug Overdose Deaths More Than Quadrupled from 1999 to 2020
Regardless of race, age, geography or urbanization, drug overdose deaths in the U.S. more than quadrupled from 1999 to 2020, causing 1,013,852 deaths. The rates increased 4.4 times from 6.9 per 100,000 in 1999 to 30 per 100,000 in 2020.
HEAL expands naloxone access to turn the tide on overdose deaths
Aug. 31 marks International Overdose Awareness Day, a time when attention is directed toward raising awareness about opioid overdose and ways to reverse the deadly effects.
Fentanyl Can Be Weaponized. Preparation Could Minimize the Damage.
Rutgers experts have identified risks and created a basic strategy for protecting public health.
FDA’s approval of over-the-counter naloxone will save lives
The American Society of Anesthesiologists (ASA) urges the public to help fight the opioid epidemic by learning to recognize and respond to an overdose. This includes understanding how to use naloxone, a life-saving medication approved today for sale over the counter by the U.S. Food and Drug Administration.
Anesthesiologists, including one who lost both sons to opioid overdose, crusade for over-the-counter naloxone access
Physician anesthesiologist Bonnie Milas, M.D., experienced firsthand the power of naloxone – a drug that reverses opioid overdose – having used it to save her son when she found him unresponsive on the kitchen floor. With drug overdose deaths hitting…
Fentanyl overdoses are on the rise. Here’s what to know and how you can help.
Community awareness is critical to preventing overdoses
American Society of Anesthesiologists Express Strong Support for Over-the-Counter Naloxone Use
In a letter to the U.S. Food and Drug Administration (FDA), the American Society of Anesthesiologists (ASA) expressed its strong support of naloxone nasal spray products for non-prescription use. Naloxone, a safe life-saving medication that rapidly reverses an opioid overdose and significantly reduces the incidence of opioid overdose deaths, should be available to all patients across the United States as a nonprescription treatment, according to the ASA.
Researchers Endorse Widespread Naloxone Over the Counter to Prevent Drug Overdose Deaths
Naloxone is an opioid receptor antagonist that rapidly reverses or blocks the effects of opioids, restores normal respiration and heart rhythm, and reverses the potentially fatal effects of an overdose. Although naloxone is included in U.S. CDC recommendations, the drug is currently prescribed to less than 1 in 70 patients prescribed high-dose opioid prescriptions. Researchers propose a call to action for all health providers and state medical societies to ensure the widest distribution and easy availability of naloxone, including over the counter, which is likely to be FDA-approved very soon.
IU study explored how people’s beliefs impact overdose education and naloxone distribution programs
A new study by Indiana University researchers, published in the journal BMC Public Health, explored people’s beliefs about overdose and naloxone as a step to understanding why some communities are not using the reversal medication.
IU study explored how people’s beliefs impact overdose education and naloxone distribution programs
A new study by Indiana University researchers explored people’s beliefs about overdose and naloxone as a step to understanding why some communities are not using the reversal medication.
Just over half of Michigan pharmacies offer overdose-fighting naloxone without prescription
Despite the ability of any Michigan pharmacy to dispense medication to combat opioid overdose without writing prescriptions, slightly more than half of pharmacies in the state offer the drug in such a way.
Drug Historian Offers Insight on Dramatic Surge of Opioid Overdoses
Preliminary data from the Centers for Disease Control and Prevention released recently show that deaths from opioid overdoses surged during the pandemic. This week, a New York Times story called it “an increasingly urgent public health crisis,” noting that the…
Carrying Naloxone Can Save Lives but Newly Abstinent Opioid Users Resist
UC San Diego School of Medicine researchers report that opioid users who participated in a 12-step abstinence program and recently stopped using drugs refused to take home naloxone, even if having it on hand might save lives.
Arkansas Society of Anesthesiologists and American Society of Anesthesiologists Applaud Arkansas Senate Public Health Committee on Passing SB 505 Giving Protection to Patients Prescribed Opioids
The Arkansas Society of Anesthesiologists (ARSA) and the American Society of Anesthesiologists (ASA) today applaud bill sponsor Sen. Cecile Bledsoe and the Arkansas Senate Public Health, Labor and Welfare Committee for helping to ensure the safety of patients prescribed opioids. Arkansas State Drug Director Kirk Lane and Jonathan Goree, M.D., a physician anesthesiologist and pain medicine specialist, testified for the bill.
Real-time opioid overdose tracking system shows rise in the time of COVID-19
An epidemic that was already raging before COVID-19 arrived has flared up in recent months, according to a real-time tracking system in Michigan. It shows a 15 percent rise in suspected opioid overdose deaths since March, compared with the same time last year, and a 29% rise in first responders’ use of the rescue drug naloxone.
New York Nightlife Venues Recruited in Effort to Prevent Overdoses Due to Fentanyl
Bars and nightclubs are a promising site for efforts to increase awareness of the risk of opioid overdose due to fentanyl-laced cocaine, suggests a study in the Journal of Public Health Management and Practice (JPHMP). The journal is published in the Lippincott portfolio by Wolters Kluwer.
Recognize an overdose, save a life
Every day nearly 200 people die from an overdose of drugs or from alcohol poisoning, with opioids responsible for the majority. Recognizing the signs and knowing how to respond to medical emergencies, including carrying and administering naloxone in cases of opioid overdose, can save lives says the ASA.
This drug could save their lives, but less than 2% of them get it
Only a tiny minority of people at risk for an opioid overdose actually are prescribed a drug that could save their lives, a new study suggests. And the odds of having a dose of the rescue drug were very low among some of the most at-risk groups, including those who had already survived a previous opioid overdose.